By Staff
Wednesday, January 26, 2022 12:15 AM
ST. LOUIS—
The Canadian Association of Optometrists (CAO) has endorsed the
World Council of Optometry (WCO) myopia management as
standard of care resolution. In a
position statement, the CAO said that it supports the WCO resolution and endorses evidence-based myopia management as a standard of care for all at-risk patients. The CAO recognizes that myopia is a global public health issue and cannot be considered merely an inconvenience of uncorrected vision. CAO president Dr. Harry Bohnsack said, “Since the World Health Organization’s release of the World Report on Vision in 2019, CAO’s Council has been concerned about the increasing prevalence of myopia globally.
By Staff
Tuesday, January 25, 2022 12:15 AM
CARLSBAD, Calif.—
SynergEyes, a leader in specialty contact lens technology, has established an exclusive distribution agreement with
EyePrint Prosthetics, according to an announcement Monday. The alliance enables SynergEyes to offer the ScanFitPRO lens, which combines elevation specific technology with exciting new developments in the field of ocular topographical scanning, to its customers and their patients. The new partnership was announced at the 2022 Global Specialty Lens Symposium (GSLS) in Las Vegas. SynergEyes is planning to commercialize the SynergEyes ScanFitPRO lens in the third quarter of 2022.
By Staff
Monday, January 24, 2022 12:21 AM
SOPHIA ANTIPOLIS, France—
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, reported net revenue of €3.5 million for the fourth quarter of 2021 ended Dec. 31, 2021, versus net revenue of €5.8 million for the fourth quarter of 2020.
By Staff
Monday, January 24, 2022 12:18 AM
MIAMI—On Jan. 21, 1962,
Bascom Palmer Eye Institute, the University of Miami Miller School of Medicine Department of Ophthalmology, officially opened its doors as the first center in the southeastern U.S. devoted exclusively to the study and treatment of the eye.
By Staff
Friday, January 21, 2022 12:27 AM
LAVAL, QC—
Bausch Health Companies has announced that Dr. Yehia Hashad will join
Bausch + Lomb Corp. as executive vice president of research & development (R&D) and chief medical officer (CMO), effective Jan. 31.
By Staff
Friday, January 21, 2022 12:21 AM
COLUMBIA, Md.—
The Foundation Fighting Blindness announced the promotion of Jason Menzo to president and chief operating officer, effective immediately.
By Staff
Thursday, January 20, 2022 12:24 AM
NORTH CHICAGO, Ill.—
Allergan, an
AbbVie (NYSE: ABBV) company, announced this week a series of executive changes within the leadership of its eyecare group.
By Staff
Thursday, January 20, 2022 12:18 AM
SAN DIEGO—
Eyes On Eyecare has announced that registration is officially open for Eyes On Dry Eye 2022. The three-day virtual educational summit is scheduled for March 4-6, 2022.
By Staff
Wednesday, January 19, 2022 12:15 AM
WICHITA, Kan.—Organizers of the Envision Conference through Envision University are excited to return to an in-person conference experience in 2022 with outstanding programs and opportunities for professionals in the vision rehabilitation field.
By Staff
Tuesday, January 18, 2022 12:24 AM
ST. LOUIS—The
American Optometric Association’s (AOA) nationwide public awareness campaign is making waves and reinforcing the essential care doctors of optometry deliver.
By Staff
Tuesday, January 18, 2022 12:21 AM
MINNETONKA, Minn.—
UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, said it will invest in new ways to help children and adults across the country reduce their exposure to blue light and support their overall eye health, amid ongoing use of screens during COVID-19 and the greater reliance on remote school and work.
By Staff
Tuesday, January 11, 2022 1:11 PM
January is Glaucoma Awareness Month, and
Bausch + Lomb released new data from a survey of glaucoma patients to better understand the impact of hyperemia in their glaucoma treatment and lives. The survey, which was conducted in partnership with the
Glaucoma Research Foundation, uncovered the emotional and social cost of hyperemia on glaucoma patients, the impact hyperemia has on treatment adherence and the need for conversations between patients and their eyecare professionals to find the right treatment option for them.
By Staff
Tuesday, January 11, 2022 12:21 AM
GENEVA—
Alcon (SIX/NYSE: ALC) yesterday announced the closing of its previously announced acquisition of
Ivantis, developer of the novel Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery.